Profile data is unavailable for this security.
About the company
Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is engaged in the commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. It is engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. Its diversified portfolio is comprised of virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. It operates in Australia, United States, China and Japan. Its products offering include NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, and others.
- Revenue in AUD (TTM)2.16m
- Net income in AUD-2.43m
- Incorporated2016
- Employees--
- LocationBeroni Group LtdSuite 401, 447 Kent StreetSYDNEY 2000AustraliaAUS
- Phone+61 28051-3055
- Websitehttps://www.beronigroup.com/